Related Experiment Video
Updated: May 13, 2026
06:19
Screening Ion Channels in Cancer Cells
Published on: June 16, 2023
Solute carriers (SLCs) in cancer
Sara El-Gebali1, Susanne Bentz, Matthias A Hediger
1Institute of Biochemistry and Molecular Medicine, University of Bern, Bern, Switzerland.
Molecular Aspects of Medicine
|March 20, 2013
Summary
Solute carriers (SLCs) are crucial in cancer metabolism, transporting essential macromolecules. Targeting SLCs offers new therapeutic strategies for cancer treatment, including direct targeting and drug delivery.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Metabolism
Background:
- Tumor progression involves altered cellular metabolism to meet increased energy and nutrient demands.
- All major macromolecule classes (carbohydrates, proteins, lipids, nucleic acids) are affected during tumorigenesis.
- Solute carriers (SLCs), the primary transporters for these macromolecules, exhibit altered expression in cancer cells.
Purpose of the Study:
- To review the multifaceted roles of solute carriers (SLCs) in cancer therapy.
- To explore the potential of SLCs as direct or indirect therapeutic targets.
- To discuss SLCs as drug carriers and their role in chemosensitization.
Main Methods:
- Literature review summarizing current research on SLCs in cancer.
- Analysis of SLC expression patterns in tumor cells.
- Discussion of therapeutic strategies targeting SLCs.
Main Results:
- SLCs are differentially expressed in tumors, reflecting altered metabolic needs.
- Targeting upregulated SLCs can inhibit tumor growth by restricting nutrient supply.
- SLCs can be exploited for targeted drug delivery and to modulate chemotherapy response.
Conclusions:
- Solute carriers represent promising targets for novel cancer therapies.
- Modulating SLC activity offers potential for direct anti-cancer effects, enhanced drug delivery, and improved chemosensitivity.
- Further research into SLCs is warranted to fully realize their therapeutic potential in oncology.
More Related Videos
Related Concept Videos
01:55Secondary Active Transport
One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme “pump” embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
01:32Secondary Active Transport
One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme "pump" embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
01:23Transcellular Transport of Solutes
Transcellular transport of solutes is the movement of substances like monosaccharides and amino acids through polarized cells. This transport mechanism is primarily seen in epithelial and endothelial cells aided by membrane transport proteins such as channels and transporters. The tight junctions between these cells confine the membrane proteins to the two sides of the cell. The epithelial cells have distinct apical and basolateral domains. In contrast, the endothelial cells show the luminal...
01:31Membrane Transporters
Transporters are essential membrane transport proteins with functions related to cell nutrition, homeostasis, communication, etc. Approximately 7% of all genes in the human genome code for transporters or transporter-related proteins.
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...